Nurix Therapeutics(NRIX) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

NRIX Nurix Therapeutics

Watchlist

13.590
+0.400+3.03%

Close Mar 14 16:00 ET

13.590
0.0000.00%

Post 16:23 ET

1.03BMarket Cap-4.72P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Nurix Therapeutics Treatment of Waldenstrom Macroglobulinemia Gets Orphan Status
TipRanksMar 13 18:25 ET
Press Release: Nurix Therapeutics Appoints Drug Development Expert Roy D. Baynes, MB.Bch., M.Med., Ph.D., to Its Board of Directors
Dow JonesMar 13 16:00 ET
Some Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shareholders Look For Exit As Shares Take 28% Pounding
Simply Wall StMar 4 05:07 ET
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswireFeb 14 16:01 ET
Express News | Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ReutersFeb 14 16:01 ET
Stifel Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $36
Moomoo NewsFeb 11 07:31 ET · Ratings

Comments

Benjamin Franklin 76

Mar 14 16:18

$Nurix Therapeutics (NRIX.US)$

Trytosaveabit

Mar 14 08:07

TRYING TO VERIFY!

$Nurix Therapeutics (NRIX.US)$ But watching close ifn it’s FACTUAL? Dont see anything on Company website! but here is what i seen and wanted to share just in case its true?????
(((((((. Nurix Therapeutics treatment of Waldenstrom macroglobulinemia gets orphan status
Mar. 13, 2025, 05:25 PM
Nurix Therapeutics (NRIX)’ treatment of Waldenstrom macroglobulinemia was granted FDA orphan designation, according to a post on the agency’s website.